PTC Therapeutics, Inc. (PTCT) Balance Sheet
PTCT balance sheet, 2025
December 31, 2025 · U.S. dollars$2.90B assets = $3.10B liabilities + −$205.3M equity
Liabilities exceed assets: shareholders’ equity is negative (−$205.3M).
Both columns are drawn to the same scale: what PTCT owns equals what it owes plus shareholders’ equity. Hover a block for its value.
PTCT financial health
Descriptive bands, not a rating. Fiscal 2025.
PTCT balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $269.3M2016 | $2.90B2025 | +30.2%/yr | |
| Total liabilities | $149.8M2016 | $3.10B2025 | +40.0%/yr | |
| Shareholders’ equity | $119.6M2016 | −$205.3M2025 | — | |
| Cash & short-term investments | $231.7M2016 | $1.95B2025 | +26.7%/yr | |
| Total debt | $139.1M2016 | $2.71B2025 | +39.1%/yr | |
| Net cash (debt) | $92.6M2016 | −$761.7M2025 | −$854.3M | |
| Working capital | $211.7M2016 | $1.31B2025 | +$1.1B | |
| Book value per share | $3.512016 | −$2.322025 | — | |
| Current ratio | 5.272016 | 2.352025 | −2.92 | |
| Debt / equity | 1.162016 | 307.172021 | +306.00 | |
| Shares outstanding | 34.0M2016 | 88.3M2025 | +11.2%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
PTCT assets
PTCT liabilities and equity
PTCT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
PTCT balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $1.95B | $1.14B | $876.7M | $410.7M | $773.4M | $1.10B | $686.6M | $227.6M | $191.2M | $231.7M |
| Cash & equivalents | $984.6M | $779.7M | $594.0M | $279.8M | $773.4M | $208.8M | $288.0M | $227.6M | $191.2M | $231.7M |
| Short-term investments | $960.7M | $360.0M | $282.7M | $130.9M | $583.7M | $894.8M | $398.5M | $58.1M | $79.5M | $173.3M |
| Receivables | $181.6M | $158.6M | $160.8M | $155.6M | $110.5M | $69.9M | $55.5M | $67.9M | $40.4M | $24.9M |
| Inventory | $79.6M | $23.2M | $30.6M | $21.8M | $15.9M | $18.7M | $19.3M | $16.1M | $10.8M | $1.7M |
| Other current assets | $67.3M | $44.1M | $150.5M | $105.7M | $0 | $39.5M | $17.9M | $9.2M | $6.7M | $3.0M |
| Total current assets | $2.27B | $1.37B | $1.22B | $693.8M | $773.4M | $1.23B | $779.3M | $320.9M | $249.1M | $261.3M |
| Property, plant & equipment (net) | $135.4M | $117.7M | $179.0M | $175.0M | $130.0M | $118.2M | $35.2M | $12.7M | $8.4M | $7.4M |
| Goodwill & intangible assets | $471.1M | $201.1M | $461.8M | $788.2M | $807.2M | $797.7M | $792.8M | $783.4M | $266.0M | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $18.3M | $20.7M | $36.2M | $48.6M | $227.5M | $60.6M | $16.4M | $2.3M | $0 | $630,000 |
| Total assets | $2.90B | $1.71B | $1.90B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $391.7M | $269.3M |
| Liabilities | ||||||||||
| Accounts payable | $45.5M | $17.3M | $6.0M | $27.3M | $23.0M | $18.7M | $10.3M | $6.0M | $15.3M | $6.3M |
| Short-term debt | $585.1M | $271.2M | $210.3M | $84.5M | $159.8M | $8.7M | $25.2M | $11.7M | $61.2M | $40.9M |
| Deferred revenue | $2.0M | $5.5M | $801,000 | $1.4M | $265.8M | $4.2M | $8.2M | $3.7M | $3.9M | $1.6M |
| Total current liabilities | $968.4M | $581.0M | $603.1M | $406.2M | $509.3M | $277.3M | $235.9M | $166.8M | $82.0M | $49.6M |
| Long-term debt | $2.03B | $2.11B | $1.90B | $571.7M | $281.9M | $309.1M | $293.9M | $141.3M | $145.0M | $98.2M |
| Lease obligations | $112.1M | $103.9M | $130.8M | $131.9M | $103.9M | $111.3M | — | — | — | — |
| Other long-term liabilities | $110.3M | $112.7M | $207.2M | $1.07B | $883.5M | $1.14B | $499.7M | $460.4M | $8.2M | $1.9M |
| Total liabilities | $3.10B | $2.80B | $2.71B | $2.05B | $1.94B | $1.73B | $1.03B | $768.5M | $235.2M | $149.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $80,000 | $77,000 | $75,000 | $72,000 | $71,000 | $70,000 | $62,000 | $51,000 | $42,000 | $34,000 |
| Retained earnings (deficit) | −$2.96B | −$3.65B | −$3.28B | −$2.66B | −$2.10B | −$1.63B | −$1.19B | −$938.9M | −$814.1M | −$735.1M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | $10.5M | −$25.9M | −$1.3M | $4.8M | −$24.3M | −$61.0M | −$10.6M | $1.5M | $4.0M | −$1.5M |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | −$205.3M | −$1.10B | −$818.6M | −$347.1M | $1.4M | $482.0M | $594.3M | $350.7M | $156.4M | $119.6M |
| Key figures | ||||||||||
| Total debt | $2.71B | $2.47B | $2.23B | $1.46B | $441.7M | $420.4M | $328.0M | $153.0M | $206.1M | $139.1M |
| Net cash (debt) | −$761.7M | −$1.33B | −$1.35B | −$1.05B | $331.7M | $683.2M | $358.5M | $74.6M | −$14.9M | $92.6M |
| Working capital | $1.31B | $784.5M | $615.5M | $287.5M | $264.0M | $954.4M | $543.4M | $154.1M | $167.0M | $211.7M |
| Tangible book value | −$676.4M | −$1.30B | −$1.28B | −$1.14B | −$805.7M | −$315.7M | −$198.5M | −$432.6M | −$109.5M | $119.6M |
| Book value per share | −$2.32 | −$14.29 | −$10.94 | −$4.84 | $0.02 | $7.30 | $10.10 | $7.53 | $3.99 | $3.51 |
| Shares outstanding | 88.3M | 76.8M | 74.8M | 71.7M | 70.5M | 66.0M | 58.9M | 46.6M | 39.2M | 34.0M |
| Current ratio | 2.35 | 2.35 | 2.02 | 1.71 | 1.52 | 4.44 | 3.30 | 1.92 | 3.04 | 5.27 |
| Quick ratio | 2.20 | 2.23 | 1.72 | 1.39 | 1.74 | 4.23 | 3.15 | 1.77 | 2.82 | 5.17 |
| Debt / equity | — | — | — | — | 307.17 | 0.87 | 0.55 | 0.44 | 1.32 | 1.16 |
| Equity / assets | −7.1% | −64.4% | −43.2% | −20.3% | 0.1% | 21.8% | 36.6% | 31.3% | 39.9% | 44.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $2.23B | $1.89B | $1.95B | $1.69B | $1.99B | $2.03B | $1.14B | $1.01B | $1.09B | $884.8M | $876.7M | $294.8M |
| Cash & equivalents | $1.05B | $834.0M | $984.6M | $672.6M | $1.02B | $1.48B | $779.7M | $526.0M | $654.8M | $548.4M | $594.0M | $165.2M |
| Short-term investments | $1.18B | $1.06B | $960.7M | $1.02B | $971.8M | $547.0M | $360.0M | $487.4M | $438.5M | $336.5M | $282.7M | $129.7M |
| Receivables | $239.0M | $219.9M | $181.6M | $203.1M | $196.1M | $210.5M | $158.6M | $200.0M | $187.2M | $197.7M | $160.8M | $165.7M |
| Inventory | $91.4M | $75.6M | $79.6M | $52.7M | $34.1M | $21.7M | $23.2M | $35.7M | $31.8M | $30.1M | $30.6M | $35.8M |
| Other current assets | $57.9M | $66.1M | $67.3M | $64.2M | $53.5M | $57.1M | $44.1M | $32.5M | $45.6M | $56.2M | $150.5M | $44.1M |
| Total current assets | $2.62B | $2.25B | $2.27B | $2.01B | $2.27B | $2.32B | $1.37B | $1.28B | $1.36B | $1.17B | $1.22B | $540.4M |
| Property, plant & equipment (net) | $126.3M | $129.4M | $135.4M | $137.7M | $113.4M | $116.8M | $117.7M | $122.6M | $123.1M | $184.0M | $179.0M | $179.1M |
| Goodwill & intangible assets | $485.3M | $463.0M | $471.1M | $478.8M | $226.1M | $200.8M | $201.1M | $412.7M | $412.2M | $412.4M | $461.8M | $505.7M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $21.6M | $22.6M | $18.3M | $19.4M | $21.8M | $21.4M | $20.7M | $25.3M | $23.1M | $24.5M | $36.2M | $34.7M |
| Total assets | $3.25B | $2.87B | $2.90B | $2.64B | $2.63B | $2.66B | $1.71B | $1.84B | $1.92B | $1.79B | $1.90B | $1.26B |
| Liabilities | ||||||||||||
| Accounts payable | $40.4M | $25.5M | $45.5M | $36.6M | $26.5M | $15.2M | $17.3M | $13.3M | $24.3M | $27.5M | $6.0M | $19.2M |
| Short-term debt | $73.4M | $305.0M | $585.1M | $300.8M | $17.1M | $16.5M | $271.2M | $16.8M | $16.0M | $16.5M | $210.3M | $14.3M |
| Deferred revenue | $1.2M | $498,000 | $2.0M | $1.7M | $9.8M | $12.8M | $5.5M | — | $3.7M | $1.8M | $801,000 | $1.2M |
| Total current liabilities | $771.1M | $923.6M | $968.4M | $866.2M | $627.8M | $595.4M | $581.0M | $610.7M | $609.8M | $574.5M | $603.1M | $492.1M |
| Long-term debt | $535.5M | $0 | $2.03B | $0 | $286.0M | $285.7M | $2.11B | $285.1M | $284.8M | $284.5M | $1.90B | $573.2M |
| Lease obligations | $105.5M | $108.2M | $112.1M | $123.8M | $102.2M | $103.9M | $103.9M | $115.1M | $110.7M | $136.9M | $130.8M | $131.2M |
| Other long-term liabilities | $2.11B | $2.13B | $110.3M | $1.93B | $1.93B | $1.96B | $112.7M | $2.00B | $2.00B | $1.82B | $207.2M | $865.4M |
| Total liabilities | $3.42B | $3.05B | $3.10B | $2.80B | $2.84B | $2.84B | $2.80B | $2.90B | $2.90B | $2.68B | $2.71B | $1.93B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $82,000 | $81,000 | $80,000 | $79,000 | $78,000 | $78,000 | $77,000 | $76,000 | $76,000 | $76,000 | $75,000 | $75,000 |
| Retained earnings (deficit) | −$2.88B | −$2.97B | −$2.96B | −$2.83B | −$2.85B | −$2.78B | −$3.65B | −$3.58B | −$3.47B | −$3.38B | −$3.28B | −$3.13B |
| Accumulated other comprehensive income | $6.0M | $8.5M | $10.5M | $5.9M | $7.4M | −$13.9M | −$25.9M | −$4.3M | −$16.5M | −$5.6M | −$1.3M | $9.6M |
| Total shareholders' equity | −$165.4M | −$180.5M | −$205.3M | −$155.8M | −$206.5M | −$185.8M | −$1.10B | −$1.05B | −$980.2M | −$893.9M | −$818.6M | −$670.8M |
| Key figures | ||||||||||||
| Total debt | $696.5M | $395.1M | $2.71B | $410.1M | $388.2M | $389.6M | $2.47B | $400.2M | $395.5M | $421.4M | $2.23B | $704.4M |
| Net cash (debt) | $1.53B | $1.50B | −$761.7M | $1.28B | $1.60B | $1.64B | −$1.33B | $613.2M | $697.8M | $463.4M | −$1.35B | −$409.5M |
| Working capital | $1.85B | $1.33B | $1.31B | $1.14B | $1.65B | $1.72B | $784.5M | $670.8M | $748.1M | $594.2M | $615.5M | $48.2M |
| Tangible book value | −$650.6M | −$643.5M | −$676.4M | −$634.6M | −$432.7M | −$386.5M | −$1.30B | −$1.47B | −$1.39B | −$1.31B | −$1.28B | −$1.18B |
| Book value per share | −$1.80 | −$2.19 | −$2.54 | −$1.79 | −$2.64 | −$2.15 | −$14.22 | −$13.71 | −$12.78 | −$11.69 | −$10.84 | −$8.90 |
| Shares outstanding | 92.0M | 82.5M | 80.7M | 87.1M | 78.2M | 86.4M | 77.2M | 76.9M | 76.7M | 76.5M | 75.5M | 75.4M |
| Current ratio | 3.39 | 2.44 | 2.35 | 2.32 | 3.62 | 3.89 | 2.35 | 2.10 | 2.23 | 2.03 | 2.02 | 1.10 |
| Quick ratio | 3.20 | 2.29 | 2.20 | 2.18 | 3.48 | 3.76 | 2.23 | 1.99 | 2.10 | 1.88 | 1.72 | 0.94 |
| Equity / assets | −5.1% | −6.3% | −7.1% | −5.9% | −7.8% | −7.0% | −64.4% | −57.2% | −51.1% | −49.9% | −43.2% | −53.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 19, 2026); data from EODHD.
PTCT financial position
At the end of fiscal 2025 (December 31, 2025), PTC Therapeutics had total assets of $2.9 billion (up 70.0% from a year earlier), total liabilities of $3.1 billion and shareholders' equity of -$205.3 million. It held $1.9 billion in cash and short-term investments against $2.7 billion of debt, net debt of $761.7 million. Its current ratio was 2.35. In the latest quarter (ended June 30, 2026) total assets were $3.3 billion and equity -$165.4 million.
Related: PTCT income statement, PTCT cash flow statement, PTCT key metrics. See the PTCT stock overview for the latest quote and news.
PTCT balance sheet FAQ
What are PTC Therapeutics's total assets?
PTC Therapeutics reported total assets of $2.9 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.7 billion a year earlier.
How much debt does PTC Therapeutics have?
PTC Therapeutics had $2.7 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does PTC Therapeutics have?
PTC Therapeutics held $1.9 billion in cash and short-term investments at the end of fiscal 2025; with $2.7 billion of debt that is net debt of $761.7 million.
What is PTC Therapeutics's book value?
PTC Therapeutics's shareholders' equity (book value) was -$205.3 million at the end of fiscal 2025, or −$2.32 per share.
What is PTC Therapeutics's current ratio?
PTC Therapeutics had current assets of $2.3 billion and current liabilities of $968.4 million, a current ratio of 2.35 (it can cover its short-term obligations).
How much goodwill does PTC Therapeutics have?
PTC Therapeutics carried $471.1 million of goodwill and intangible assets, 16.3% of total assets, at the end of fiscal 2025.